Company intelligence / Profile preview

Xelaro

Between London and Cambridge, United Kingdomxelaro.com ↗

Ownership: Private
Development stage: Commercial

Overview

Xelaro is a UK-based medicinal chemistry consultancy led by Dr. Mike Rowley, who has over 30 years of experience in drug discovery. The company provides expert consulting services in medicinal chemistry to support pharmaceutical and biotech R&D projects at various stages of the drug discovery process.

Modalities: Small molecule
Industry: Drug Discovery Services

Drug pipeline

3 assets

raltegravir

Commercial

Indications: HIV

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Xelaro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xelaro.

Explore the full profile